全球胃腸道糞便檢驗市場

預計到 2030 年全球胃腸道糞便檢驗市場規模將達到 8.919 億美元

全球胃腸道糞便檢驗市場規模預計在2024年為6.308億美元，到2030年將達到8.919億美元，在2024-2030年的分析期內，複合年成長率為5.9%。胃腸道糞便檢驗耗材是本報告分析的細分市場之一，預計其複合年成長率為4.7%，到分析期結束時規模將達到5.011億美元。糞便檢驗檢測分析儀細分市場在分析期間的複合年成長率預計為7.7%。

美國市場預計將達到 1.719 億美元，而中國市場預計將以 9.2% 的複合年成長率成長

預計到2024年，美國胃腸道糞便檢驗市場規模將達到1.719億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到1.792億美元，在2024-2030年的分析期間內，複合年成長率為9.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.0%和5.8%。在歐洲，預計德國市場的複合年成長率為3.9%。

全球胃腸道糞便檢驗市場—主要趨勢和促進因素摘要

為什麼胃腸道糞便檢驗成為重要的診斷工具？

胃腸道 (GI)糞便檢驗已成為檢測多種消化系統疾病、感染疾病和發炎的重要診斷方法。這種非侵入性檢測方法使醫療保健專業人員能夠分析糞便樣本中是否存在與消化系統疾病相關的病原體、血液、消化酵素和生物標記。由於腸道健康對整體健康至關重要，近年來對準確且便捷的糞便檢驗解決方案的需求顯著成長。

微生物組分析和分子診斷技術的進步正在進一步提高胃腸道糞便檢驗的準確性和適用範圍。糞便大便潛血試驗(FOBT)、糞便鈣衛蛋白檢測以及基於多重 PCR 的糞便病原體檢測等檢測正在改善大腸直腸癌、發炎性腸道疾病 (IBD) 和細菌感染的早期診斷。隨著功能醫學和個人化醫療的興起，糞便檢驗也被用於評估腸道菌叢組成，有助於標靶治療大腸激躁症(IBS) 和小腸細菌過度生長 (SIBO) 等疾病。

哪些醫療應用推動了對胃腸道糞便檢驗的需求？

胃腸道糞便檢驗在胃腸病學中廣泛用於診斷大腸直腸癌、發炎性腸道疾病和胃腸道感染疾病。糞便免疫化學檢查(FIT) 和糞便潛血檢查 (FOBT) 能夠早期發現糞便檢體中的潛血，已成為大腸直腸癌篩檢的標準工具。此外，糞便鈣衛蛋白和乳鐵蛋白檢測常用於區分發炎性腸道疾病和功能性胃腸病，從而減少了對大腸鏡檢查等侵入性檢查的需求。

感染疾病診斷是消化道糞便檢驗發揮關鍵作用的另一個關鍵領域。多重PCR檢測組能夠快速檢測細菌、病毒和寄生蟲感染，進而改善治療效果並減少抗生素濫用。人們對腸道菌叢健康的認知不斷提高，也導致了對糞便菌叢分析的需求增加，這有助於深入了解與腸道菌叢失調相關的疾病，例如肥胖、糖尿病和自體免疫疾病。糞便檢驗與常規健康體檢和精準醫療計劃的整合，進一步推動了市場擴張。

胃腸道糞便檢驗的最新創新是什麼？

近期的技術進步顯著提高了胃腸糞便檢驗的效率、準確性和可及性。最具創新性的發展之一是採用次世代定序儀(NGS) 進行腸道微生物組分析，從而能夠全面分析胃腸道中的細菌、真菌和病毒群落。此外，人工智慧主導的診斷平台正在與糞便檢驗相結合，從而實現結果的自動解讀和個人化治療建議。

另一項重大技術創新是家用糞便檢測套組的開發，它使患者無需前往醫療機構即可採集樣本並送至實驗室進行分析。這些直接面對消費者的檢測方法正在改善胃腸道健康評估的可近性，尤其是預防性篩檢和微生物組檢測。基於CRISPR的糞便樣本中特定病原體檢測診斷方法也正在興起，提供超靈敏和快速的檢測能力。這些進展使胃腸道糞便檢驗更加準確、便捷，並具有臨床價值。

哪些因素推動了胃腸道糞便檢驗市場的成長？

胃腸道糞便檢驗市場的成長受到多種因素的推動，包括胃腸道疾病盛行率的上升、非侵入性診斷方法的普及以及分子檢測技術的進步。全球大腸直腸癌、發炎性腸道疾病和腸道細菌相關疾病的負擔加劇了對早期精準診斷解決方案的需求。政府主導腸癌篩檢計畫進一步推動了糞便檢測的普及。

微生物組研究的不斷擴展以及消費者對腸道健康日益成長的興趣也促進了市場的成長。直接面對消費者的微生物組分析服務日益普及，這些服務根據糞便檢驗結果提供個人化的飲食和益生菌建議。此外，攜帶式診斷設備和數位健康平台的進步也提高了糞便檢測在臨床和家庭環境中的可近性。隨著胃腸道診斷技術的不斷發展，預計腸道糞便檢驗將在精準醫療、疾病預防和最佳化腸道健康方面發揮關鍵作用。

部分

產品（胃腸道糞便檢驗耗材、胃腸道糞便檢驗分析儀）；檢測（潛血檢測、細菌檢測、糞便生物標記檢測、蟲卵和寄生蟲檢測、其他檢測類型）；應用（感染疾病應用、癌症應用、發炎性腸道疾病應用、胃食道逆流症應用、其他應用） ；

受訪公司範例

• Abbott Laboratories
• Beckman Coulter, Inc.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cardinal Health, Inc.
• Cenogenics Corporation
• CTK Biotech, Inc.
• Danaher Corporation
• DiaSorin SpA
• Epitope Diagnostics, Inc.
• Exact Sciences Corporation
• Genova Diagnostics
• Hologic, Inc.
• Meridian Bioscience, Inc.
• Nanosphere, Inc.
• Quest Diagnostics
• Roche Diagnostics
• ScheBo Biotech AG
• Siemens Healthineers
• Trinity Biotech

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global GI Stool Testing Market to Reach US$891.9 Million by 2030

The global market for GI Stool Testing estimated at US$630.8 Million in the year 2024, is expected to reach US$891.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. GI Stool Testing Consumables, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$501.1 Million by the end of the analysis period. Growth in the GI Stool Testing Analyzers segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$171.9 Million While China is Forecast to Grow at 9.2% CAGR

The GI Stool Testing market in the U.S. is estimated at US$171.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$179.2 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global GI Stool Testing Market - Key Trends & Drivers Summarized

Why Is GI Stool Testing Becoming an Essential Diagnostic Tool?

Gastrointestinal (GI) stool testing has become an indispensable diagnostic method for detecting a wide range of digestive disorders, infections, and inflammatory conditions. This non-invasive testing approach allows healthcare professionals to analyze stool samples for the presence of pathogens, blood, digestive enzymes, and biomarkers associated with gastrointestinal diseases. As gut health plays a crucial role in overall wellness, the demand for accurate and accessible stool testing solutions has grown significantly in recent years.

Advancements in microbiome analysis and molecular diagnostic techniques have further enhanced the accuracy and scope of GI stool testing. Tests such as fecal occult blood tests (FOBT), fecal calprotectin assays, and multiplex PCR-based stool pathogen detection have improved early diagnosis of colorectal cancer, inflammatory bowel disease (IBD), and bacterial infections. With the rise of functional medicine and personalized healthcare, stool testing is also being used to assess gut microbiota composition, aiding in targeted treatments for conditions such as irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).

Which Medical Applications Are Driving Demand for GI Stool Testing?

GI stool testing is widely used in gastroenterology for the diagnosis of colorectal cancer, inflammatory bowel disease, and gastrointestinal infections. Fecal immunochemical tests (FIT) and FOBT have become standard tools for colorectal cancer screening, enabling early detection of occult blood in stool samples. Additionally, stool calprotectin and lactoferrin tests are commonly used to distinguish between inflammatory bowel disease and functional GI disorders, reducing the need for invasive procedures such as colonoscopy.

Infectious disease diagnostics is another major area where GI stool testing plays a crucial role. Multiplex PCR panels allow for the rapid detection of bacterial, viral, and parasitic infections, improving treatment outcomes and reducing antibiotic misuse. The growing awareness of gut microbiome health has also led to increased demand for stool-based microbiota profiling, providing insights into dysbiosis-related conditions such as obesity, diabetes, and autoimmune disorders. The integration of stool testing into routine health check-ups and precision medicine initiatives is further driving market expansion.

What Are the Latest Technological Innovations in GI Stool Testing?

Recent technological advancements have significantly improved the efficiency, accuracy, and accessibility of GI stool testing. One of the most transformative developments is the adoption of next-generation sequencing (NGS) for gut microbiome analysis, enabling comprehensive profiling of bacterial, fungal, and viral communities within the digestive tract. Additionally, AI-driven diagnostic platforms are being integrated with stool testing, allowing for automated interpretation of results and personalized treatment recommendations.

Another key innovation is the development of at-home stool test kits, which allow patients to collect and send samples for laboratory analysis without visiting healthcare facilities. These direct-to-consumer tests have increased accessibility to gastrointestinal health assessments, particularly for preventive screenings and microbiome testing. The use of CRISPR-based diagnostic methods for detecting specific pathogens in stool samples is also emerging, offering ultra-sensitive and rapid detection capabilities. These advancements are making GI stool testing more precise, user-friendly, and clinically valuable.

What Factors Are Fueling the Growth of the GI Stool Testing Market?

The growth in the GI stool testing market is driven by several factors, including rising prevalence of gastrointestinal diseases, increasing adoption of non-invasive diagnostics, and technological advancements in molecular testing. The global burden of colorectal cancer, inflammatory bowel diseases, and gut microbiome-related disorders has fueled demand for early and accurate diagnostic solutions. Government-led colorectal cancer screening programs have further boosted the adoption of stool-based tests.

The expansion of microbiome research and the growing consumer interest in gut health have also contributed to market growth. Direct-to-consumer microbiome analysis services have gained popularity, offering personalized dietary and probiotic recommendations based on stool test results. Additionally, advancements in portable diagnostic devices and digital health platforms have improved accessibility to stool-based testing in both clinical and at-home settings. As gastrointestinal diagnostics continue to evolve, GI stool testing is expected to play a vital role in precision medicine, disease prevention, and gut health optimization.

SCOPE OF STUDY:

The report analyzes the GI Stool Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (GI Stool Testing Consumables, GI Stool Testing Analyzers); Test (Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test, Other Test Types); Application (Infection Application, Cancer Application, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications); Distribution Channel (Brick & Mortar Distribution Channel, E-Commerce Distribution Channel); End-Use (Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Beckman Coulter, Inc.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Cardinal Health, Inc.
• Cenogenics Corporation
• CTK Biotech, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Epitope Diagnostics, Inc.
• Exact Sciences Corporation
• Genova Diagnostics
• Hologic, Inc.
• Meridian Bioscience, Inc.
• Nanosphere, Inc.
• Quest Diagnostics
• Roche Diagnostics
• ScheBo Biotech AG
• Siemens Healthineers
• Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • GI Stool Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Gastrointestinal Disorders and Colorectal Cancer Drives Demand for Stool Testing
  • Increased Public Awareness of Gut Health and Microbiome-Linked Conditions Spurs Adoption of Stool-Based Diagnostics
  • Expansion of Non-Invasive Screening Methods Supports Shift from Endoscopy to Stool Testing in Early Diagnosis
  • Growth in At-Home Testing and Telehealth Services Fuels Demand for Mail-In Stool Sample Kits
  • OEM Innovation in Molecular and Microbiome Analysis Enhances Diagnostic Accuracy and Functional GI Insights
  • Rising Use of Stool Tests in Pediatric and Geriatric GI Care Expands Demographic Reach
  • Integration of AI and Digital Health Platforms Enables Personalized Interpretation of Stool Test Results
  • Growing Role of Fecal Biomarkers in IBD and IBS Management Strengthens Market for Targeted Stool Testing
  • Increased Healthcare Payer Coverage and Inclusion in Routine Screening Protocols Drive Adoption
  • Expansion of Microbiome Therapeutics and Probiotic Research Spurs Demand for Gut Health Analysis Tools
  • Growing Availability of FDA-Approved Fecal Immunochemical Tests (FIT) Enhances Colorectal Screening Programs
  • Data Integration with EHRs and Digital Pathology Tools Improves Longitudinal GI Health Monitoring
  • Use of Stool Testing in Food Sensitivity and Digestive Enzyme Analysis Expands Wellness Applications
  • Rising Interest in Personalized Nutrition and Diet Optimization Drives Growth in Microbiome-Based Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World GI Stool Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for GI Stool Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for GI Stool Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for GI Stool Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for GI Stool Testing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for GI Stool Testing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for GI Stool Testing Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for GI Stool Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for GI Stool Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for GI Stool Testing Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Inflammatory Bowel Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Inflammatory Bowel Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Inflammatory Bowel Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Gastroesophageal Reflux Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Gastroesophageal Reflux Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Gastroesophageal Reflux Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Infection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Infection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Brick & Mortar Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Brick & Mortar Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Brick & Mortar Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for E-Commerce Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for E-Commerce Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for E-Commerce Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Homecare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Homecare Settings End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Homecare Settings End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Occult Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Occult Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Occult Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Bacteria Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Bacteria Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Bacteria Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Fecal Biomarkers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Fecal Biomarkers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Fecal Biomarkers Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Ova & Parasites Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Ova & Parasites Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Ova & Parasites Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 59: USA Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• JAPAN
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• CHINA
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• EUROPE
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 119: Europe Recent Past, Current & Future Analysis for GI Stool Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for GI Stool Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for GI Stool Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• FRANCE
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 137: France Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 143: France Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: France Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: France 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 146: France Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: France 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• GERMANY
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 152: Germany Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Germany 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 155: Germany Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Germany Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Germany 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 158: Germany Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Germany Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Germany 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 161: Germany Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 167: Italy Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Italy Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Italy 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 170: Italy Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Italy Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Italy 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 173: Italy Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 182: UK Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: UK Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: UK 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 185: UK Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 197: Spain Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Spain Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Spain 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 200: Spain Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 212: Russia Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Russia Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Russia 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 215: Russia Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 221: Russia Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Russia 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Europe 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Europe 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for GI Stool Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for GI Stool Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Asia-Pacific 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 260: Australia Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Australia Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Australia 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 263: Australia Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Australia Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Australia 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 266: Australia Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Australia Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Australia 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 269: Australia Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Australia 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• INDIA
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 275: India Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: India Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: India 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 278: India Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: India Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: India 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 281: India Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: India Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: India 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 284: India Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: India 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 290: South Korea Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: South Korea Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: South Korea 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: South Korea Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: South Korea 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: South Korea Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: South Korea 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: South Korea 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Asia-Pacific Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Asia-Pacific 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 321: Latin America Historic Review for GI Stool Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Latin America 15-Year Perspective for GI Stool Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Latin America Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Latin America 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Latin America Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Latin America 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Latin America 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 338: Argentina Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Argentina Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Argentina 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Argentina Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Argentina 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Argentina Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Argentina 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Argentina 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 353: Brazil Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Brazil Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Brazil 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Brazil Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Brazil 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Brazil Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Brazil 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Brazil 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 368: Mexico Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Mexico Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: Mexico 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Mexico Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: Mexico 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Mexico Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Mexico 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Mexico 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Latin America Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Latin America 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Latin America 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Latin America 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 399: Middle East Historic Review for GI Stool Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Middle East 15-Year Perspective for GI Stool Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Middle East Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Middle East 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Middle East Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 406: Middle East 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 409: Middle East 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 416: Iran Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Iran Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 418: Iran 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 419: Iran Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Iran Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 421: Iran 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 422: Iran Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Iran Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 424: Iran 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 425: Iran Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 427: Iran 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 431: Israel Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Israel Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 433: Israel 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 434: Israel Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Israel Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 436: Israel 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 437: Israel Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Israel Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 439: Israel 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 440: Israel Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 442: Israel 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Saudi Arabia Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 448: Saudi Arabia 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 451: Saudi Arabia 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 454: Saudi Arabia 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 461: UAE Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 462: UAE Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 463: UAE 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 464: UAE Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 465: UAE Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 466: UAE 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 467: UAE Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 468: UAE Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 469: UAE 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 470: UAE Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 472: UAE 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Rest of Middle East Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 478: Rest of Middle East 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 481: Rest of Middle East 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 484: Rest of Middle East 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030
• AFRICA
  • GI Stool Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 491: Africa Recent Past, Current & Future Analysis for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Africa Historic Review for GI Stool Testing by Product - GI Stool Testing Consumables and GI Stool Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 493: Africa 15-Year Perspective for GI Stool Testing by Product - Percentage Breakdown of Value Sales for GI Stool Testing Consumables and GI Stool Testing Analyzers for the Years 2015, 2025 & 2030
  • TABLE 494: Africa Recent Past, Current & Future Analysis for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Africa Historic Review for GI Stool Testing by Application - Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 496: Africa 15-Year Perspective for GI Stool Testing by Application - Percentage Breakdown of Value Sales for Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Other Applications, Infection Application and Cancer Application for the Years 2015, 2025 & 2030
  • TABLE 497: Africa Recent Past, Current & Future Analysis for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Africa Historic Review for GI Stool Testing by Distribution Channel - Brick & Mortar Distribution Channel and E-Commerce Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 499: Africa 15-Year Perspective for GI Stool Testing by Distribution Channel - Percentage Breakdown of Value Sales for Brick & Mortar Distribution Channel and E-Commerce Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 500: Africa Recent Past, Current & Future Analysis for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for GI Stool Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 502: Africa 15-Year Perspective for GI Stool Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Homecare Settings End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for GI Stool Testing by Test - Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for GI Stool Testing by Test - Percentage Breakdown of Value Sales for Occult Blood Test, Bacteria Test, Fecal Biomarkers Test, Ova & Parasites Test and Other Test Types for the Years 2015, 2025 & 2030

IV. COMPETITION